Aarti Drugs Limited Stock Price To Earnings To Growth
AARTIDRUGS | 444.75 10.40 2.28% |
Aarti Drugs Limited fundamentals help investors to digest information that contributes to Aarti Drugs' financial success or failures. It also enables traders to predict the movement of Aarti Stock. The fundamental analysis module provides a way to measure Aarti Drugs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aarti Drugs stock.
Aarti | Price To Earnings To Growth |
Aarti Drugs Limited Company Price To Earnings To Growth Analysis
Aarti Drugs' PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Competition |
Based on the latest financial disclosure, Aarti Drugs Limited has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Pharmaceuticals sector and about the same as Health Care (which currently averages 0.0) industry. The price to earnings to growth for all India stocks is 100.0% higher than that of the company.
Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
All Next | Launch Module |
Aarti Fundamentals
Return On Equity | 0.12 | ||||
Return On Asset | 0.0617 | ||||
Profit Margin | 0.06 % | ||||
Operating Margin | 0.09 % | ||||
Current Valuation | 47.18 B | ||||
Shares Outstanding | 91.27 M | ||||
Shares Owned By Insiders | 61.84 % | ||||
Shares Owned By Institutions | 9.51 % | ||||
Price To Book | 3.26 X | ||||
Price To Sales | 1.71 X | ||||
Revenue | 25.09 B | ||||
Gross Profit | 8.06 B | ||||
EBITDA | 3.2 B | ||||
Net Income | 1.71 B | ||||
Total Debt | 5.64 B | ||||
Book Value Per Share | 139.96 X | ||||
Cash Flow From Operations | 3.59 B | ||||
Earnings Per Share | 16.59 X | ||||
Target Price | 555.0 | ||||
Number Of Employees | 1.06 K | ||||
Beta | 0.83 | ||||
Market Capitalization | 40.59 B | ||||
Total Asset | 24.32 B | ||||
Retained Earnings | 11.55 B | ||||
Working Capital | 5.25 B | ||||
Annual Yield | 0 % | ||||
Net Asset | 24.32 B |
About Aarti Drugs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aarti Drugs Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aarti Drugs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aarti Drugs Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Aarti Stock Analysis
When running Aarti Drugs' price analysis, check to measure Aarti Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarti Drugs is operating at the current time. Most of Aarti Drugs' value examination focuses on studying past and present price action to predict the probability of Aarti Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarti Drugs' price. Additionally, you may evaluate how the addition of Aarti Drugs to your portfolios can decrease your overall portfolio volatility.